Summary for 9U6A
| Entry DOI | 10.2210/pdb9u6a/pdb |
| Descriptor | Tubulin alpha-1B chain, Tubulin beta chain, Designed Ankyrin Repeat Protein (DARPIN) D1, ... (7 entities in total) |
| Functional Keywords | tubulin, cell cycle |
| Biological source | synthetic construct More |
| Total number of polymer chains | 3 |
| Total formula weight | 117997.44 |
| Authors | |
| Primary citation | Su, Y.,Yan, W.,Yang, J.,Yang, F. Structure of quercetin 3,4'-dimethyl ether in complex with tubulin provides a rationale for drug design. Biochem.Biophys.Res.Commun., 777:152245-152245, 2025 Cited by PubMed Abstract: Microtubules, composed of αβ-tubulin heterodimers, serve as key targets for anticancer therapeutics due to their critical role in cell division. Numerous compounds have been discovered to interact with tubulin and disrupt microtubule dynamics, particularly those targeting the colchicine-binding domain. Certain flavones, for instance, have demonstrated the ability to bind to this site and suppress microtubule polymerization. Despite their potential, progress in developing flavone-based drugs has been limited by insufficient structural data on tubulin-ligand complexes. Here, we present the high-resolution (1.92 Å) crystal structure of tubulin in complex with a flavone derivative, quercetin 3,4'-dimethyl ether (QU34), elucidating the specific molecular interactions at atomic detail. By analyzing this structure alongside other colchicine-site inhibitors, we clarify prior structure-activity relationship (SAR) findings and offer a framework for designing optimized flavone analogs targeting this site. PubMed: 40578283DOI: 10.1016/j.bbrc.2025.152245 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.92 Å) |
Structure validation
Download full validation report






